News | April 01, 2025
Briefs: AstraZeneca Pharma India, Pharmaids and Dr. Agarwal's Health Care
AstraZeneca Pharma India discontinues manufacturing of Imdur
AstraZeneca Pharma India discontinues manufacturing of Imdur
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
The emergence of new infections in India is a growing concern
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Subscribe To Our Newsletter & Stay Updated
